Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
PA21
print preview
bookmark
share with colleague
General Information
Company
Galenica Ltd.
Description
Oral iron-based phosphate binder
Molecular Target
Mechanism of Action
Latest Stage of Development
Registration
Indication
Hyperphosphatemia
Partner
Fresenius SE & Co. KGaA
;
Kissei Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy